Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7461 p83
21 July 2007


Society summary


Opinion Leader commissioned to identify members' expectations

Hemant Patel

The President: solid commitment

The Royal Pharmaceutical Society has awarded the research-based consultancy Opinion Leader a contract to carry out important research among the organisation's membership. The research will be designed to identify the needs, wants and expectations of members and other stakeholders in the light of the Government's decision to separate the Society's regulatory and professional functions.

The results will be used by the Society’s Council to inform the development of business models for a future professional body as well as to inform future consultation processes.

The Society says that, after a rigorous tendering process, Opinion Leader was awarded the commission because it demonstrated considerable experience in the health, regulatory and membership organisation fields. The London-based company has previously conducted research for the Department of Health, the Chartered Society of Physiotherapists and the Healthcare Commission.

The Society’s President, Hemant Patel, said: “The commission of this research underlines a solid commitment by the Society to fully involve all stakeholders in decisions relating to the future of pharmacy. At a time of great and rapid change we must understand the needs and long-term ambitions of our members so that discussions to form a professional body for pharmacy are based on evidence.

“Opinion Leader has a wealth of experience executing research projects of this nature and has a genuine understanding of the core issues we are addressing. I would encourage selected Society members and other individuals from pharmacy bodies to engage fully in this process, which is set to have a significant impact on the future of our professional leadership.”

The Society began sending official written invitations to participate in the research to individuals this week. The research programme will take 12 weeks to conduct.

Back to Top


©The Pharmaceutical Journal